In VivoPharma’s AI moment has arrived—not as a futuristic vision, but as a pragmatic engine of operational and scientific change. To understand how biopharma companies are navigating this shift, Define Ventu
ScripUS President Donald Trump appears to be giving the drug industry more time to voluntarily come up with ways to bring American drug prices more in line with those paid by other wealthy nations, a sign
Pink SheetUS President Donald Trump appears to be giving the drug industry more time to voluntarily come up with ways to bring American drug prices more in line with those paid by other wealthy nations, a sign
ScripWhen the US Food and Drug Administration approved Alnylam Pharmaceuticals’ Amvuttra (vutrisiran) for cardiomyopathy in patients with wild-type or hereditary transthyretin-mediated amyloidosis (ATTR-CM